title: [Clinical value of the model for end-stage liver disease score in predicting the prognosis of liver transplantation in patients with end-stage liver disease].
abstract: OBJECTIVE
  To assess the value of the model for end-stage liver disease (MELD) in predicting the early-stage outcome of liver transplantation in patients with end-stage liver disease.
  
  
  METHODS
  The MELD scores of 87 liver transplantation recipients with end-stage liver disease were calculated, and their early-stage complications and mortality were analyzed.
  
  
  RESULTS
  The incidence of severe complications was 20.7%; in these recipients, with the 28-day and 3-month survival rates of 89.7%; and 88.5%;, respectively. The mean MELD scores showed significant differences between the complication-free group and survival group (14.6 vs 12.9, P<0.05), and also between the complication group and death group (21.6 vs 29.4, P<0.05). Compared to patients with MELD no greater than 15, patients with MELD between 16 and 24 showed significantly increased complication rate but had comparable survival rate (P>0.05); but in patients with MELD no less than 25, the survival rate was significantly decreased with also increased complication rate.
  
  
  CONCLUSIONS
  A higher MELD score before liver transplantation is associated with greater likeliness of early-stage complication rate and mortality. High MELD score (over 25) can be a useful index in predicting severe complications and death in patients undergoing liver transplantation.
authors.affiliation: Department of Medical Intensive Care Unit, Guangzhou General Hospital of Guangzhou Command, Guangzhou, China.
authors.forename: Jie
authors.initials: J
authors.lastname: Sun
authors.forename: Zhen-hui
authors.initials: ZH
authors.lastname: Guo
authors.forename: Tian-shun
authors.initials: TS
authors.lastname: Lai
authors.forename: You-qing
authors.initials: YQ
authors.lastname: Tang
authors.forename: Lei
authors.initials: L
authors.lastname: Su
authors.forename: Feng
authors.initials: F
authors.lastname: Huo
authors.forename: Shao-ping
authors.initials: SP
authors.lastname: Wang
authors.forename: Miao-shui
authors.initials: MS
authors.lastname: Pu
authors.forename: Qiang
authors.initials: Q
authors.lastname: Wen
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D019694:Hepatitis B, Chronic / Q000150:complications; D006801:Humans; D008103:Liver Cirrhosis / Q000209:etiology / Q000601:surgery; D017093:Liver Failure / Q000209:etiology / Q000473:pathology / Q000601:surgery*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D011379:Prognosis; D012189:Retrospective Studies; D012720:Severity of Illness Index; D016019:Survival Analysis; D055815:Young Adult